Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
eli lilly
11
×
fda
11
×
biotech
life sciences
national blog main
clinical trials
boston blog main
boston top stories
national top stories
europe blog main
indiana blog main
indiana top stories
new york blog main
san francisco blog main
national
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san francisco top stories
abbvie
allergan
amgen
boulder/denver blog main
boulder/denver top stories
cancer
detroit blog main
detroit top stories
europe top stories
san diego blog main
san diego top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
deals
glaxosmithkline
investing
ipo
What
fda
drug
new
bio
roundup
approval
eli
medicines
won
biotech
black
cancer
companies
days
diamond
drugs
leading
life
lilly
lilly’s
medicine
migraine
pharmaceutical
regulatory
science
therapeutics
treatment
wins
acute
addresses
adults
alkermes
allergan
alliance
antibody
antipsychotic
approved
august
authorized
bails
Language
unset
11
×
Current search:
unset
×
" eli lilly "
×
fda
×
@bgr.com
3 years ago
FDA just authorized a breakthrough coronavirus drug that’s proven to save lives
@xconomy.com
3 years ago
FDA Panel Vote Weighs in Favor of Alkermes Psyche Drug, With Caveats
@xconomy.com
3 years ago
Bio Roundup: CRISPR Kudos, Bristol Myers’s Buy, RNAi Alliance & More
@xconomy.com
3 years ago
Roche, Blueprint Medicines Team Up Again in $775M RET Cancer Drug Pact
@xconomy.com
4 years ago
FDA Rejects Boehringer Ingelheim, Eli Lilly Drug for Type 1 Diabetes
@xconomy.com
4 years ago
Bio Roundup: Mammoth Moves, Black Diamond’s Pop, Ohana’s Debut & More
@xconomy.com
4 years ago
Black Diamond Lines Up IPO as Lead Cancer Drug Nears Clinic
@xconomy.com
4 years ago
Allergan Wins FDA Nod for First Migraine Pill in New Class of Medicines
@xconomy.com
4 years ago
Bio Roundup: Ichnos Emerges, Beyond CAR-T, BridgeBio Bails & More
@xconomy.com
4 years ago
FDA OKs Lilly’s Lasmiditan, First New Acute Migraine Drug in Decades
@xconomy.com
4 years ago
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More